Prof. Dr. med. Matthias Heck
Lehrstuhlinhaber
Urologie
| Telefon: | +49 (0)821 400-2870 |
| E-Mail: | matthias.heck@uk-augsburguk-augsburg.de () |
| Adresse: | Stenglinstra?e 2, 86156 Augsburg |
Zur Person
Publikationen
2025
|
2024
|
2023
|
2022
|
2021
|
2025 |
|
Gabler N., Kirchhoff S., Sauter A., Heck Matthias, Lorenzini T., Haller B., Weber W., Eiber M., Rauscher I..
18F-Flotufolastat PET/MR in suspicious prostate cancer: correlation with histopathological biopsy-results [Abstract].
BibTeX | RIS |
|
Knipper Sophie, Lischewsk Flemming, Koehler Daniel, Eiber Matthias, van Leeuwen Fijs W. B., de Barros Hilda, Berrens Anne-Claire, Zuur Lotte, van Leeuwen Pim J., van der Poel Henk, Ambrosini Francesca, Falkenbach Fabian, Bud?us Lars, Steuber Thomas, Graefen Markus, Tennstedt Pierre, Gschwend Jürgen E., Horn Thomas, Heck Matthias M., Maurer Tobias.
Biochemical response of <0.1 ng/ml predicts therapy-free survival of prostate cancer patients following prostate-specific membrane antigen–targeted salvage surgery.
https://doi.org/10.1016/j.euo.2024.04.019
BibTeX | RIS | DOI |
|
Karimzadeh A., Fütterer C., Hansen K., Heck Matthias, Tauber R., D'Alessandria C., Weber W., Eiber M., Rauscher I..
External validation of baseline 68Ga-PSMA-11 PET-based prediction models using 18F-flotufolastat PET in patients with metastatic castration-resistant prostate cancer receiving 177Lu-labeled PSMA-targeted radioligand therapy [Abstract].
BibTeX | RIS |
|
Gammel M., Olufs C., Brosch-Lenz J., Heck Matthias, Weber W., Eiber M., Rauscher I..
Insights into renal split function assessment via PSMA-ligand PET/CT [Abstract].
BibTeX | RIS |
|
Schweiger Lilit, Maurer Tobias, Simon Ricarda, Horn Thomas, Heck Matthias M., Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
Pattern of failure in patients with biochemical recurrence after PSMA radioguided surgery.
BibTeX | RIS |
|
Karimzadeh Amir, Hansen Kimberley, Hasa Ergela, Haller Bernhard, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer.
https://doi.org/10.1007/s00259-024-07003-2
BibTeX | RIS | DOI |
|
Falkenbach Fabian, Lischewski Flemming, Knipper Sophie, Koehler Daniel, Karakiewicz Pierre I., Tian Zhe, Saad Fred, Tilki Derya, Bud?us Lars, Steuber Thomas, Mandel Philipp, Wenzel Mike, Gschwend Jürgen E., Graefen Markus, Heck Matthias M., Maurer Tobias.
Prostate-specific membrane antigen–radioguided surgery in an EMBARK-like cohort of patients with oligorecurrent hormone-sensitive prostate cancer: delay in systemic treatment.
BibTeX | RIS |
|
2024 |
|
Karimzadeh Amir, Hecker Charlotte-Sophie, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment interval.
https://doi.org/10.1186/s13550-024-01143-0
BibTeX | RIS | DOI |
|
2023 |
|
Karimzadeh Amir, Heck Matthias, Tauber Robert, Knorr Karina, Haller Bernhard, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
177 Lu-PSMA-I&T for treatment of metastatic castration-resistant prostate cancer: prognostic value of scintigraphic and clinical biomarkers.
BibTeX | RIS |
|
Knipper S., Lischewski F., Koehler D., Eiber M., Van Leeuwen F. W. B., De Barros H., Berrens A., Van Leeuwen P., Van Der Poel H., Falkenbach F., Bud?us L., Steuber T., Graefen M., Gschwend J. E., Tennstedt P., Horn T., Heck Matthias M., Maurer T..
A1122 - Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of patients treated with salvage lymph node dissection via PSMA-radioguided surgery [Abstract].
BibTeX | RIS |
|
Knipper Sophie, Mehdi Irai Mehrdad, Simon Ricarda, Koehler Daniel, Rauscher Isabel, Eiber Matthias, van Leeuwen Fijs W. B., van Leeuwen Pim, de Barros Hilda, van der Poel Henk, Bud?us Lars, Steuber Thomas, Graefen Markus, Tennstedt Pierre, Heck Matthias M., Horn Thomas, Maurer Tobias.
Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via prostate-specific membrane antigen (PSMA) radioguided surgery.
BibTeX | RIS |
|
Knipper S., Lischewski F., Koehler D., Eiber M., van Leeuwen F. W. B., de Barros H., Berrens A. C., van Leeuwen P., van der Poel H., Ambrosini F., Falkenbach F., Bud?us L., Steuber T., Graefen M., Tennstedt P., Gschwend J. E., Horn T., Heck Matthias M., Maurer T..
Complete biochemical response below 0.1 ng/ml predicts long-term therapy-free survival of prostate cancer patients treated with salvage lymph node dissection via PSMA-radioguided surgery [Abstract].
https://doi.org/10.1016/s2666-1683(23)01298-3
BibTeX | RIS | DOI |
|
Muehlematter Urs J., Schweiger Lilit, Ferraro Daniela A., Hermanns Thomas, Maurer Tobias, Heck Matthias M., Rupp Niels J., Eiber Matthias, Rauscher Isabel, Burger Irene A..
Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer.
https://doi.org/10.1007/s00259-023-06278-1
BibTeX | RIS | DOI |
|
Falkenbach Fabian, Ambrosini Francesca, Tennstedt Pierre, Eiber Matthias, Heck Matthias M., Preisser Felix, Graefen Markus, Bud?us Lars, Koehler Daniel, Knipper Sophie, Maurer Tobias.
EAU biochemical recurrence risk classification and PSA kinetics have no value for patient selection in PSMA-radioguided surgery (PSMA-RGS) for oligorecurrent prostate cancer.
https://doi.org/10.3390/cancers15205008
BibTeX | RIS | DOI |
|
Spohn Simon K. B., Draulans Cédric, Kishan Amar U., Spratt Daniel, Ross Ashley, Maurer Tobias, Tilki Derya, Berlin Alejandro, Blanchard Pierre, Collins Sean, Bronsert Peter, Chen Ronald, Dal Pra Alan, de Meerleer Gert, Eade Thomas, Haustermans Karin, H?lscher Tobias, H?cht Stefan, Ghadjar Pirus, Davicioni Elai, Heck Matthias M., Kerkmeijer Linda G. W., Kirste Simon, Tselis Nikolaos, Tran Phuoc T., Pinkawa Michael, Pommier Pascal, Deltas Constantinos, Schmidt-Hegemann Nina-Sophie, Wiegel Thomas, Zilli Thomas, Tree Alison C., Qiu Xuefeng, Murthy Vedang, Epstein Jonathan I., Graztke Christian, Gao Xin, Grosu Anca L., Kamran Sophia C., Zamboglou Constantinos.
Genomic classifiers in personalized prostate cancer radiation therapy approaches: a systematic review and future perspectives based on international consensus.
https://doi.org/10.1016/j.ijrobp.2022.12.038
BibTeX | RIS | DOI |
|
Groeben Christer, Boehm Katharina, Koch Rainer, Sonntag Ulrich, Nestler Tim, Struck Julian, Heck Matthias, Baunacke Martin, Uhlig Annemarie, Koelker Mara, Meyer Christian P., Becker Benedikt, Salem Johannes, Huber Johannes, Leitsmann Marianne.
Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study.
https://doi.org/10.1007/s00345-022-04271-1
BibTeX | RIS | DOI |
|
Hekimsoy T., Heck Matthias M., Gschwend J. E., Schwamborn K., Eiber M., Weber W..
How many unnecessary prostate biopsies can be avoided by PSMA PET/MR? [Abstract].
BibTeX | RIS |
|
Karimzadeh A., Soeiro P., Feuerecker B., Heck Matthias M., Tauber R., Knorr K., D'Alessandria C., Weber W., Eiber M., Rauscher I..
Improved quality of life in mCRPC patients receiving consecutive cycles of 177Lu-PSMA RLT [Abstract].
BibTeX | RIS |
|
Karimzadeh Amir, Soeiro Paula, Feuerecker Benedikt, Hecker Charlotte-Sophie, Knorr Karina, Heck Matthias M., Tauber Robert, D'Alessandria Calogero, Weber Wolfgang, Eiber Matthias, Rauscher Isabel.
Improved quality of life in metastatic castration-resistant prostate cancer patients receiving consecutive cycles of 177Lu-PSMA I&T.
BibTeX | RIS |
|
Jahnen Matthias, Heck Matthias M..
Kommentar zu: Radikale Prostatektomie beim oligometastasierten Prostatakarzinom.
BibTeX | RIS |
|
Ambrosini Francesca, Falkenbach Fabian, Bud?us Lars, Graefen Markus, Koehler Daniel, Lischewski Flemming, Gschwend Juergen E., Heck Matthias M., Eiber Matthias, Knipper Sophie, Maurer Tobias.
Prevalence of bilateral loco-regional spread in unilateral pelvic PSMA PET positive recurrent prostate cancer.
BibTeX | RIS |
|
Meagher Margaret F., Mir Maria C., Minervini Andrea, Kriegmair Maximilian, Heck Matthias M., Porpiglia Francesco, Van Bruwaene Siska, Linares Estefania, Hevia Vital, D'Anna Maurizio, Veccia Alessandro, Roussel Eduard, Claps Francesco, Palumbo Carlotta, Marchioni Michele, Afari Jonathan, Saitta Cesare, Liu Franklin, Rubio Jose, Campi Riccardo, Mari Andrea, Amiel Thomas, Checcucci Enrico, Musquera Mireia, Guruli Georgi, Pavan Nicola, Albersen Maarten, Antonelli Alessandro, Klatte Tobias, Autorino Riccardo, McKay Rana R., Derweesh Ithaar H..
Proposal for a two-tier re-classification of stage IV/M1 domain of renal cell carcinoma into M1 ("oligometastatic") and M2 ("polymetastatic") subdomains: analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC).
https://doi.org/10.3389/fonc.2023.1113246
BibTeX | RIS | DOI |
|
Lunger Lukas, Steinhelfer Lisa, Korn Philipp, Eiber Matthias, Maurer Tobias, Büchler Jakob, Horn Thomas, Gschwend Jürgen E., Heck Matthias M..
Prostate-specific membrane antigen–radioguided surgery facilitates pelvic lymph node dissection during radical prostatectomy for the treatment of locally advanced prostate cancer with regional lymph node metastases.
BibTeX | RIS |
|
Falkenbach Fabian, Knipper Sophie, Koehler Daniel, Ambrosini Francesca, Steuber Thomas, Graefen Markus, Bud?us Lars, Eiber Matthias, Lunger Lukas, Lischewski Flemming, Heck Matthias M., Maurer Tobias.
Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support.
https://doi.org/10.1007/s00345-023-04534-5
BibTeX | RIS | DOI |
|
Seifert Robert, Emmett Louise, Rowe Steven P., Herrmann Ken, Hadaschik Boris, Calais Jeremie, Giesel Frederik L., Reiter Robert, Maurer Tobias, Heck Matthias M., Gafita Andrei, Morris Michael J., Fanti Stefano, Weber Wolfgang A., Hope Thomas A., Hofman Michael S., Fendler Wolfgang Peter, Eiber Matthias.
Second version of the prostate cancer molecular imaging standardized evaluation framework including response evaluation for clinical trials (PROMISE?V2).
https://doi.org/10.1016/j.eururo.2023.02.002
BibTeX | RIS | DOI |
|
Karimzadeh Amir, Heck Matthias M., Tauber Robert, Solaris Esteban, Nekolla Stephan, Knorr Karina, Haller Bernhard, D'Alessandria Calogero, Weber Wolfgang A., Eiber Matthias, Rauscher Isabel.
The impact of PSMA PET–based eligibility criteria used in the prospective phase II TheraP trial in metastatic castration-resistant prostate cancer patients undergoing prostate-specific membrane antigen–targeted radioligand therapy.
BibTeX | RIS |
|
Lunger Lukas, Eiber Matthias, Heck Matthias M..
Theranostik.
BibTeX | RIS |
|
Herms Elena, Weirich Gregor, Maurer Tobias, Wagenpfeil Stefan, Preuss Stephanie, Sauter Andreas, Heck Matthias, G?rtner Anita, Hauner Katharina, Autenrieth Michael, Kübler Hubert P., Holzapfel Konstantin, Schwarz-Boeger Ulrike, Heemann Uwe, Slotta-Huspenina Julia, Stock Konrad Friedrich.
Ultrasound-based "CEUS-Bosniak" classification for cystic renal lesions: an 8-year clinical experience.
https://doi.org/10.1007/s00345-022-04094-0
BibTeX | RIS | DOI |
|
2022 |
|
Zaum R., Hein S., Rauscher I., Weber W. A., Gafita A., Heck Matthias, Eiber M..
177-Lu-PSMA I&T therapy in patients with metastatic castration-resistant prostate cancer (mCRPC): evaluation of treatment response using PSMA-ligand PET/CT [Abstract].
BibTeX | RIS |
|
Ilhan Harun, Kroenke Markus, Wurzer Alexander, Unterrainer Marcus, Heck Matthias, Belka Claus, Knorr Karina, Langbein Thomas, Rauscher Isabel, Schmidt-Hegemann Nina-Sophie, Schiller Kilian, Bartenstein Peter, Wester Hans-Jürgen, Eiber Matthias.
18F-rhPSMA-7 PET for the detection of biochemical recurrence of prostate cancer after curative-intent radiation therapy: a bicentric retrospective study.
BibTeX | RIS |
|
Herms E., Slotta-Huspenin J., G?rtner A., Preuss S., Hauner K., Heck Matthias, Autenrieth M., Maurer T., Kübler H., Holzapfel K., Sauter A., Schwarz-Boeger U., Wagenpfeil S., Heemann U., Stock K. F..
A0053 - Ultrasound based CEUS-Bosniak classification for cystic renal lesions: an 8-year clinical experience [Abstract].
BibTeX | RIS |
|
Groeben C., Boehm K., Sonntag U., Nestler T., Struck J., Heck Matthias, Baunacke M., Uhlig A., Koelker M., Meyer C. P., Becker B., Salem J., Huber J., Leitsmann M..
A0088 - Hospital rating websites play a minor role in hospital choice of uro-oncologic patients in Germany: results of the multicentric NAVIGATOR-study [Abstract].
BibTeX | RIS |
|
Knipper S., Mehdi Irai M., Simon R., K?hler D., Isabel R., Eiber M., Van Leeuwen F. W. B., Van Leeuwen P., Bud?us L., Steuber T., Graefen M., Tennstedt P., Heck Matthias, Horn T., Maurer T..
A0511 - Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery [Abstract].
BibTeX | RIS |
|
Maurer Tobias, Mehdi Irai Mehrdad, Rauscher Isabel, Simon Ricarda, Eiber Matthias, van Leeuwen Fijs W. B., van Leeuwen Pim, Budaeus Lars, Steuber Thomas, Graefen Markus, Tennstedt Pierre, Heck Matthias, Horn Thomas, Knipper Sophie.
Cohort study of oligorecurrent prostate cancer patients: oncological outcomes of patients treated with salvage lymph node dissection via PSMA radioguided surgery [Abstract].
BibTeX | RIS |
|
Babst Christa, Amiel Thomas, Maurer Tobias, Knipper Sophie, Lunger Lukas, Tauber Robert, Retz Margitta, Herkommer Kathleen, Eiber Matthias, von Amsberg Gunhild, Graefen Markus, Gschwend Juergen, Steuber Thomas, Heck Matthias.
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancer.
https://doi.org/10.1016/j.ajur.2021.04.003
BibTeX | RIS | DOI |
|
Karimzadeh A., Schweiger L., Wehrstedt R., Heck Matthias, Tauber R., Haller B., Gschwend J. E., Knorr K., D'Alessandria C., Weber W. A., Eiber M., Rauscher I..
Evaluation of the prognostic value of the PET eligibility criteria of the TheraP trial [Abstract].
BibTeX | RIS |
|
Harke Nina N., Wagner Christian, Hermann Robert M., Hadaschik Boris A., Radtke Jan Philipp, Altay-Langguth Alev, Aufderklamm Stefan, Bach Christian, Becker-Schiebe Martina, Blana Andreas, Bruns Frank, Buse Stephan, Combs Stephanie E., Engels Christina L., Ezzibdeh Emad, Fiedler Marcel, Fischer Laura-Anna, Farzat Mahmoud, Frismann Alexander, Heck Matthias M., Henkenberens Christoph, Roesch Marie C., K?ding Christoph, Klautke Gunther, Krausewitz Philipp, Kuczyk Markus A., Leitsmann Conrad, Lettmaier Sebastian, Mahjoub Samy, Manseck Andreas, 伟德国际_伟德国际1946$娱乐app游戏enwald Daniel, Meyer Andreas, Micke Oliver, Moritz Rudolf, Ott Marcel, Peters Inga, Pokupic Sasa, Porres Daniel, Preisser Felix, Reichel Kathrin, Schneider Andreas, Schwentner Christian, Scobioala Sergiu, Truss Michael, Wegener Daniel, Wezel Felix, Willborn Kay, Witt J?rn H., Wittig Andrea, Wittlinger Michael, Wolff Hendrik A., Zimmermanns Volker, Christiansen Hans.
Lessons learned after one year of COVID-19 from a urologist and radiotherapist view: a German survey on prostate cancer diagnosis and treatment.
https://doi.org/10.1371/journal.pone.0269827
BibTeX | RIS | DOI |
|
Meissner Valentin H., Rauscher Isabel, Schwamborn Kristina, Neumann Jan, Miller Gregor, Weber Wolfgang, Gschwend Jürgen E., Eiber Matthias, Heck Matthias M..
Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography.
BibTeX | RIS |
|
Meissner Valentin H., Gschwend Jürgen E., Heck Matthias M..
Reply to Giancarlo Marra, Armando Stabile, Paolo Gontero, Francesco Montorsi, Alberto Briganti, and Giorgio Gandaglia’s Letter to the Editor re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical prostatectomy without prior biopsy following multiparametric magnetic resonance imaging and prostate-specific membrane antigen positron emission tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup [Letter].
BibTeX | RIS |
|
2021 |
|
Marchioni Michele, Cheaib Joseph G., Takagi Toshio, Pavan Nicola, Antonelli Alessandro, Everaerts Wourter, Heck Matthias, Rha Koon H., Mottrie Alexandre, Kaouk Jihad, Capitanio Umberto, Lima Estev?o, Veccia Alessandro, Crivellaro Simone, Linares Estefania, Celia Antonio, Porpiglia Francesco, Autorino Riccardo, Di Nicola Marta, Schips Luigi, Pierorazio Phillip M., Mir Maria Carmen.
Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis.
BibTeX | RIS |
|
Lunger Lukas, Retz Margitta, Bandur Miriam, Souchay Marc, Vitzthum Elisabeth, J?ger Marion, Weirich Gregor, Schuster Tibor, Autenrieth Michael, Kübler Hubert, Maurer Tobias, Thalgott Mark, Herkommer Kathleen, Koll Florestan, Gschwend Jürgen E., Nawroth Roman, Heck Matthias M..
KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.
https://doi.org/10.1038/s41391-020-00283-3
BibTeX | RIS | DOI |
|
Wuernschimmel Christoph, Amiel Thomas, Heck Matthias, Horn Thomas, Nguyen Noemi, Budaeus Lars, Knipper Sophie, Wenzel Mike, Rauscher Isabel, Eiber Matthias, Wang Hui, Maurer Tobias.
MP11-12 Regional lymph node metastasis on PSMA PET correlates with decreased BCR-free and therapy-free survival after radical prostatectomy [Abstract].
BibTeX | RIS |
|
Lunger Lukas, Tauber Robert, Feuerecker Benedikt, Gschwend Jürgen E., Eiber Matthias, Heck Matthias M..
Narrative review: prostate-specific membrane antigen-radioligand therapy in metastatic castration-resistant prostate cancer.
https://doi.org/10.21037/tau-20-1135
BibTeX | RIS | DOI |
|
Maisch Phillipp, Lunger Lukas, Düwel Charlotte, Schmid Sebastian C., Horn Thomas, Gschwend Jürgen E., Sauter Andreas, Heck Matthias M..
Outcomes of palliative cystectomy in patients with locally advanced pT4 bladder cancer.
BibTeX | RIS |
|
Karimzadeh A., Heck Matthias, Gschwend J. E., Weber W. A., Eiber M., Rauscher I..
PSMA-ligand uptake in posttherapeutic 177Lu-PSMA scintigraphy to assess response in patients with mCRPC [Abstract].
BibTeX | RIS |
|
Amiel Thomas, Würnschimmel Christoph, Heck Matthias, Horn Thomas, Nguyen Noemi, Bud?us Lars, Knipper Sophie, Wenzel Mike, Rauscher Isabel, Eiber Matthias, Wang Hui, Maurer Tobias.
Regional lymph node metastasis on prostate specific membrane antigen positron emission tomography correlates with decreased biochemical recurrence-free and therapy-free survival after radical prostatectomy: a retrospective single-center single-arm observational study.
BibTeX | RIS |